Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $7 | $21 | $15 |
| - Cash | $1 | $1 | $0 | $0 |
| + Debt | $3 | $11 | $1 | $1 |
| Enterprise Value | $2 | $17 | $22 | $16 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -19.3% | 183.7% | -80.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 25.3% | 31.3% | 53.3% | 20.9% |
| EBITDA | -$8 | -$8 | -$3 | -$1 |
| % Margin | -3,697.6% | -3,132% | -2,938.3% | -198% |
| Net Income | -$12 | -$9 | -$3 | -$1 |
| % Margin | -5,753% | -3,424.6% | -2,992.6% | -205.2% |
| EPS Diluted | -12.95 | -25.21 | -8.88 | -4.44 |
| % Growth | 48.6% | -183.9% | -100% | – |
| Operating Cash Flow | -$6 | -$6 | -$1 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$6 | -$6 | -$1 | -$1 |